FeesSafety
Pluang+

Stellar's USDT trading volume hits $200M, stablecoin volume up 121% in Q3 2026.

Protocol Fundamentals
24 Oct 2026
Tokenpost
View Source
Bullish
Stellar's USDT trading volume hits $200M, stablecoin volume up 121% in Q3 2026.

Stellar, a public blockchain for financial services, saw its USDT trading volume reach $200 million. Additionally, the overall stablecoin volume across the Stellar network rose by 121% in the third quarter of 2026 compared to the previous quarter. These figures highlight growing activity and adoption of stablecoins on the Stellar platform, indicating increased use in digital asset transactions and financial products. This trend may continue as blockchain-based stablecoins gain traction in the market.

Stellar's USDT volume and stablecoin growth provide context for digital asset trends. For readers following cryptocurrency markets, here is Pluang's snapshot as of Oct 24, 2026 17:51 WIB: out of 50 major cryptocurrencies, 5 rose and 43 fell. Notable movers include EOS with an 8.13% gain at Rp12.649, BAT down 8.76% at Rp2.874, and ONE down 7.43% at Rp24 with a 97% buy order activity.

More News

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3), used with radiotherapy and immune checkpoint inhibitors, in 24 heavily pretreated advanced melanoma patients resistant to anti-PD-1 therapies. The treatment showed a 41.7% obj...

Company Fundamentals
Bullish
26 minutes ago
Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte announced a Phase 1/2 clinical trial to test a combination of petosemtamab, INCB161734, and standard chemotherapy as a first-line treatment for metastatic colorectal cancer with the KRAS G12D mutation. This mutation is common and li...

Company Fundamentals
Bullish
26 minutes ago
AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...

Others
Neutral
2 hours ago
Bitcoin's dollar-margin long positions rise sharply, Ethereum's share declines notably on Oct 24, 2026.

Bitcoin's dollar-margin long positions rise sharply, Ethereum's share declines notably on Oct 24, 2026.

On October 24, 2026, Bitcoin's dollar-margin long position share increased by 2.34 percentage points to 63.03%, indicating growing investor confidence. Conversely, Ethereum saw a significant drop in its dollar-margin long account share by 2.13 percen...

Technical Signals
Neutral
4 hours ago
Prediction markets lower Bitcoin and Ethereum year-end price odds; XRP holds steady at 24% for $2 target.

Prediction markets lower Bitcoin and Ethereum year-end price odds; XRP holds steady at 24% for $2 target.

Prediction markets show a decline in the odds for Bitcoin and Ethereum reaching their year-end price targets, with Bitcoin's chance of hitting $100,000 dropping to 22% and Ethereum's chance of reaching $3,500 falling to 15%. XRP's probability of reac...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App